BNT162b2 vaccination effectively prevents the rapid rise of SARS-CoV-2 variant B.1.1.7 in high-risk populations in Israel

Ariel Munitz*, Matan Yechezkel, Yoav Dickstein, Dan Yamin, Motti Gerlic

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'BNT162b2 vaccination effectively prevents the rapid rise of SARS-CoV-2 variant B.1.1.7 in high-risk populations in Israel'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry